Last reviewed · How we verify

NCT05809206

Gluteus Maximus Versus Gluteus Medius Strength On Back Muscles Performance In Patients With Sacroiliac Dysfunction

Status unknown NA Last updated 12 April 2023
What this trial tests

NA trial testing Glutes maximus strength protocol in Sacroiliac Joint Dysfunction in 60 participants. Status unknown.

Timeline
10 April 2023
Primary endpoint
15 June 2023
15 August 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date10 April 2023
Primary completion15 June 2023
Estimated completion15 August 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 25 to 40, any sex, with Sacroiliac Joint Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to compare between the effect of glutes maximus and glutes medius muscles strength on back muscle performance in patients with Sacroiliac joint dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sacroiliac Joint Dysfunction

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05809206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing